Literature DB >> 26095727

Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance.

Shelton Viola1, Elie Traer2, Jianya Huan1, Noah I Hornick1, Jeffrey W Tyner2,3, Anupriya Agarwal4, Marc Loriaux2,3,5, Brian Johnstone6, Peter Kurre7,8,9.   

Abstract

Entities:  

Keywords:  acute myeloid leukaemia; chemo-resistance; exosomes; microRNA; stroma

Mesh：

Substances：

Year:  2015        PMID： 26095727      PMCID： PMC4755922          DOI： 10.1111/bjh.13551

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients.

Authors:  Guido Marcucci; Kati S Maharry; Klaus H Metzeler; Stefano Volinia; Yue-Zhong Wu; Krzysztof Mrózek; Deedra Nicolet; Jessica Kohlschmidt; Susan P Whitman; Jason H Mendler; Sebastian Schwind; Heiko Becker; Ann-Kathrin Eisfeld; Andrew J Carroll; Bayard L Powell; Jonathan E Kolitz; Ramiro Garzon; Michael A Caligiuri; Richard M Stone; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

2.  Bone marrow stroma-mediated resistance to FLT3 inhibitors in FLT3-ITD AML is mediated by persistent activation of extracellular regulated kinase.

Authors:  Xiaochuan Yang; Amy Sexauer; Mark Levis
Journal:  Br J Haematol       Date:  2013-10-10       Impact factor: 6.998

3.  BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

Authors:  Aldo M Roccaro; Antonio Sacco; Patricia Maiso; Abdel Kareem Azab; Yu-Tzu Tai; Michaela Reagan; Feda Azab; Ludmila M Flores; Federico Campigotto; Edie Weller; Kenneth C Anderson; David T Scadden; Irene M Ghobrial
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

4.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

5.  Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia.

Authors:  Zhengyan Wang; Ze Hong; Feng Gao; Weijing Feng
Journal:  Mol Cell Biochem       Date:  2013-07-18       Impact factor: 3.396

6.  Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.

Authors:  Rodrigo Jacamo; Ye Chen; Zhiqiang Wang; Wencai Ma; Min Zhang; Erika L Spaeth; Ying Wang; Venkata L Battula; Po Yee Mak; Katharina Schallmoser; Peter Ruvolo; Wendy D Schober; Elizabeth J Shpall; Martin H Nguyen; Dirk Strunk; Carlos E Bueso-Ramos; Sergej Konoplev; R Eric Davis; Marina Konopleva; Michael Andreeff
Journal:  Blood       Date:  2014-03-05       Impact factor: 22.113

7.  Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening.

Authors:  Jeffrey W Tyner; Wayne F Yang; Armand Bankhead; Guang Fan; Luke B Fletcher; Jade Bryant; Jason M Glover; Bill H Chang; Stephen E Spurgeon; William H Fleming; Tibor Kovacsovics; Jason R Gotlib; Stephen T Oh; Michael W Deininger; Christian Michel Zwaan; Monique L Den Boer; Marry M van den Heuvel-Eibrink; Thomas O'Hare; Brian J Druker; Marc M Loriaux
Journal:  Cancer Res       Date:  2012-10-18       Impact factor: 12.701

8.  Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit.

Authors:  Hind Medyouf; Maximilian Mossner; Johann-Christoph Jann; Florian Nolte; Simon Raffel; Carl Herrmann; Amelie Lier; Christian Eisen; Verena Nowak; Bettina Zens; Katja Müdder; Corinna Klein; Julia Obländer; Stephanie Fey; Jovita Vogler; Alice Fabarius; Eva Riedl; Henning Roehl; Alexander Kohlmann; Marita Staller; Claudia Haferlach; Nadine Müller; Thilo John; Uwe Platzbecker; Georgia Metzgeroth; Wolf-Karsten Hofmann; Andreas Trumpp; Daniel Nowak
Journal:  Cell Stem Cell       Date:  2014-04-03       Impact factor: 24.633

9.  Markers for characterization of bone marrow multipotential stromal cells.

Authors:  Sally A Boxall; Elena Jones
Journal:  Stem Cells Int       Date:  2012-05-14       Impact factor: 5.443

10.  Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia.

Authors:  Chang-Sook Hong; Laurent Muller; Theresa L Whiteside; Michael Boyiadzis
Journal:  Front Immunol       Date:  2014-04-10       Impact factor: 7.561
  10 in total
  24 in total

1.  Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic niche.

Authors:  Sherif Abdelhamed; John T Butler; Ben Doron; Amber Halse; Eneida Nemecek; Phillip A Wilmarth; Daniel L Marks; Bill H Chang; Terzah Horton; Peter Kurre
Journal:  EMBO Rep       Date:  2019-06-17       Impact factor: 8.807

Review 2.  Regulation of Malignant Myeloid Leukemia by Mesenchymal Stem Cells.

Authors:  Zhenya Tan; Chen Kan; Mandy Wong; Minqiong Sun; Yakun Liu; Fan Yang; Siying Wang; Hong Zheng
Journal:  Front Cell Dev Biol       Date:  2022-06-08

3.  Understanding Drug Sensitivity and Tackling Resistance in Cancer.

Authors:  Jeffrey W Tyner; Franziska Haderk; Anbarasu Kumaraswamy; Linda B Baughn; Brian Van Ness; Song Liu; Himangi Marathe; Joshi J Alumkal; Trever G Bivona; Keith Syson Chan; Brian J Druker; Alan D Hutson; Peter S Nelson; Charles L Sawyers; Christopher D Willey
Journal:  Cancer Res       Date:  2022-04-15       Impact factor: 13.312

Review 4.  Understanding the bone marrow microenvironment in hematologic malignancies: A focus on chemokine, integrin, and extracellular vesicle signaling.

Authors:  Edward Allan Racela Sison; Peter Kurre; Yong-Mi Kim
Journal:  Pediatr Hematol Oncol       Date:  2017-12-06       Impact factor: 1.969

5.  Small-sized extracellular vesicles (EVs) derived from acute myeloid leukemia bone marrow mesenchymal stem cells transfer miR-26a-5p to promote acute myeloid leukemia cell proliferation, migration, and invasion.

Authors:  Dexiang Ji; Yue He; Wei Lu; Yanyan Rong; Fei Li; Xianbao Huang; Ruibin Huang; Yanxia Jiang; Guoan Chen
Journal:  Hum Cell       Date:  2021-02-23       Impact factor: 4.174

Review 6.  Extracellular vesicle-mediated cell-cell communication in haematological neoplasms.

Authors:  Junko H Ohyashiki; Tomohiro Umezu; Kazuma Ohyashiki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-05       Impact factor: 6.237

Review 7.  Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy.

Authors:  Antonella Caivano; Francesco La Rocca; Ilaria Laurenzana; Stefania Trino; Luciana De Luca; Daniela Lamorte; Luigi Del Vecchio; Pellegrino Musto
Journal:  Int J Mol Sci       Date:  2017-06-02       Impact factor: 5.923

Review 8.  Extracellular vesicles in the hematopoietic microenvironment.

Authors:  John T Butler; Sherif Abdelhamed; Peter Kurre
Journal:  Haematologica       Date:  2018-02-08       Impact factor: 9.941

Review 9.  Extracellular Vesicles: A New Prospective in Crosstalk between Microenvironment and Stem Cells in Hematological Malignancies.

Authors:  Ilaria Laurenzana; Daniela Lamorte; Stefania Trino; Luciana De Luca; Concetta Ambrosino; Pietro Zoppoli; Vitalba Ruggieri; Luigi Del Vecchio; Pellegrino Musto; Antonella Caivano; Geppino Falco
Journal:  Stem Cells Int       Date:  2018-05-27       Impact factor: 5.443

Review 10.  The emerging roles of exosomes in leukemogeneis.

Authors:  Jianbiao Zhou; Sam Wang; Kangyun Sun; Wee-Joo Chng
Journal:  Oncotarget       Date:  2016-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.